shRNA silencing of mortalin reduced cancer cell stemness by downregulating ABCG2, OCT-4, CD133, ALDH1, CD9, MRP1, and connexin expression levels, leading to a higher ability to form spheroids (Yun et al., 2017). The gene discussed is CD9; the disease is cancer.